Vinorelbine plus trastuzumab combination as first-line therapy for HER 2-positive metastatic breast cancer patients: an international phase II trial. (Q36611699)
Jump to navigation
Jump to search
scientific article published on 12 September 2006
Language | Label | Description | Also known as |
---|---|---|---|
English | Vinorelbine plus trastuzumab combination as first-line therapy for HER 2-positive metastatic breast cancer patients: an international phase II trial. |
scientific article published on 12 September 2006 |
Statements
Vinorelbine plus trastuzumab combination as first-line therapy for HER 2-positive metastatic breast cancer patients: an international phase II trial (English)
A Chan
M Martin
M G Gil
V Guillem-Porta
P Kellokumpu-Lehtinen
H L Sommer
V Georgoulias
N Battelli
M Pawlicki
D Aubert
T Bourlard
J Gasmi
G Villanova
Navelbine Herceptin Project
12 September 2006